[go: up one dir, main page]

DK108495C - Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof. - Google Patents

Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.

Info

Publication number
DK108495C
DK108495C DK626764A DK626764A DK108495C DK 108495 C DK108495 C DK 108495C DK 626764 A DK626764 A DK 626764A DK 626764 A DK626764 A DK 626764A DK 108495 C DK108495 C DK 108495C
Authority
DK
Denmark
Prior art keywords
benzomorphans
substituted
preparation
acid addition
addition salts
Prior art date
Application number
DK626764A
Other languages
Danish (da)
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Application granted granted Critical
Publication of DK108495C publication Critical patent/DK108495C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/82Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/26Benzomorphans

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Discharge Lamp (AREA)
DK626764A 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof. DK108495C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33229663A 1963-12-20 1963-12-20

Publications (1)

Publication Number Publication Date
DK108495C true DK108495C (en) 1967-12-27

Family

ID=23297612

Family Applications (4)

Application Number Title Priority Date Filing Date
DK626764A DK108495C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.
DK429865A DK108497C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.
DK626864A DK106552C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans.
DK429765A DK108496C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK429865A DK108497C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.
DK626864A DK106552C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans.
DK429765A DK108496C (en) 1963-12-20 1964-12-19 Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.

Country Status (12)

Country Link
AT (4) AT249277B (en)
BE (2) BE657405A (en)
CH (7) CH448118A (en)
DE (2) DE1445853A1 (en)
DK (4) DK108495C (en)
ES (4) ES307302A1 (en)
FR (2) FR4346M (en)
GB (2) GB1077711A (en)
IL (2) IL22643A (en)
NL (3) NL6414821A (en)
NO (2) NO119274B (en)
SE (2) SE322779B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7501433B2 (en) 2002-05-17 2009-03-10 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US7923454B2 (en) 2002-05-17 2011-04-12 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
EP2987788A1 (en) 2002-05-17 2016-02-24 Taiwanj Pharmaceuticals Co., Ltd. Opioid and opioid-like compounds and uses thereof
US8017622B2 (en) 2003-05-16 2011-09-13 Jenken Biosciences, Inc. Opioid and opioid-like compounds and uses thereof
US8835426B2 (en) 2007-02-26 2014-09-16 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
ATE554078T1 (en) 2007-07-26 2012-05-15 Vitae Pharmaceuticals Inc SYNTHESIS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1 INHIBITORS
AR069207A1 (en) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc CYCLIC UREAS AS INHIBITORS OF THE 11 BETA - HIDROXI-ESTEROIDE DESHIDROGENASA 1
WO2009063061A2 (en) 2007-11-16 2009-05-22 Boehringer Ingelheim International Gmbh Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
CA2708303A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW200934490A (en) 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
CA2712500A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2714532A1 (en) 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
EP2245014B1 (en) * 2008-02-12 2011-11-02 Boehringer Ingelheim International GmbH Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
EP2254872A2 (en) 2008-02-15 2010-12-01 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
CL2009001059A1 (en) 2008-05-01 2010-11-12 Boehringer Ingelheim Int Compounds derived from substituted 1,3-oxazin-2-one-3.6, inhibitors of the activity of 11-beta-hydroxysteroid dehydrogenase i; pharmaceutical composition that includes them; Useful in the treatment of diseases such as diabetes mellitus, among others.
US8592410B2 (en) 2008-05-01 2013-11-26 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1
EP2291371B1 (en) 2008-05-01 2015-06-10 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2291373B1 (en) 2008-05-01 2013-09-11 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
TW200950780A (en) 2008-05-13 2009-12-16 Boehringer Ingelheim Int Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use
PE20110566A1 (en) 2008-07-25 2011-09-02 Boehringer Ingelheim Int CYCLIC INHIBITORS OF 11BETA-HYDROXIESTEROID DEHYDROGENASE 1
TW201016691A (en) 2008-07-25 2010-05-01 Boehringer Ingelheim Int Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8829027B2 (en) 2008-10-23 2014-09-09 Boehringer Ingelheim International Gmbh Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
US8637505B2 (en) 2009-02-04 2014-01-28 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8680093B2 (en) 2009-04-30 2014-03-25 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US8703765B2 (en) 2009-06-02 2014-04-22 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5656986B2 (en) 2009-06-11 2015-01-21 ヴァイティー ファーマシューティカルズ,インコーポレイテッド Cyclic inhibitor of 11β-hydroxysteroid dehydrogenase 1 based on 1,3-oxazinan-2-one structure
EP2448928B1 (en) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
UY33001A (en) 2009-11-06 2011-05-31 Boehringer Ingelheim Int ARYL AND HETEROARILCARBONYL HIVAHYDROINDENOPIRIDINE AND OCTAHYDROBENZOQUINOLINE DERIVATIVES
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
EP2585444B1 (en) 2010-06-25 2014-10-22 Boehringer Ingelheim International GmbH Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
EA201300522A1 (en) 2010-11-02 2013-11-29 Бёрингер Ингельхайм Интернациональ Гмбх PHARMACEUTICAL COMBINATIONS FOR THE TREATMENT OF METABOLIC DISORDERS
TWI537258B (en) 2010-11-05 2016-06-11 百靈佳殷格翰國際股份有限公司 Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline
JP2014524438A (en) 2011-08-17 2014-09-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Indenopyridine derivatives

Also Published As

Publication number Publication date
SE322779B (en) 1970-04-20
ES307302A1 (en) 1965-05-16
NO119273B (en) 1970-04-27
CH448118A (en) 1967-12-15
DK108496C (en) 1967-12-27
AT253687B (en) 1967-04-25
CH449643A (en) 1968-01-15
NO119274B (en) 1970-04-27
DE1445853A1 (en) 1968-12-05
GB1077711A (en) 1967-08-02
DK108497C (en) 1967-12-27
IL22643A (en) 1968-07-25
FR4346M (en) 1966-08-16
AT249276B (en) 1966-09-12
CH449641A (en) 1968-01-15
CH449642A (en) 1968-01-15
ES307300A1 (en) 1965-05-01
BE657405A (en) 1965-06-21
CH449640A (en) 1968-01-15
NL6414821A (en) 1965-06-21
AT261126B (en) 1968-04-10
SE305657B (en) 1968-11-04
CH449639A (en) 1968-01-15
CH446371A (en) 1967-11-15
DK106552C (en) 1967-02-20
AT249277B (en) 1966-09-12
NL127995C (en)
ES307299A1 (en) 1965-05-16
BE657406A (en) 1965-06-21
NL6414820A (en) 1965-06-21
GB1092394A (en) 1967-11-22
FR4345M (en) 1966-08-16
IL22642A (en) 1968-07-25
DE1445854A1 (en) 1968-12-05
ES307301A1 (en) 1965-05-16

Similar Documents

Publication Publication Date Title
DK108497C (en) Process for the preparation of substituted 6,7-benzomorphans or acid addition salts thereof.
DK108972C (en) Process for the preparation of lipoylpyridoxamine or acid addition salts thereof.
DK125421B (en) Analogous process for the preparation of 5-substituted-aza-dibenzo-cycloheptenes or acid addition salts thereof.
DK106796C (en) Process for the preparation of 3-hydroxy-5-aminomethyl-isoxazole or acid addition salts thereof.
DK116000B (en) Process for the preparation of amino-halo-benzylamines or acid addition salts thereof.
DK117000B (en) Process for the preparation of substituted phenylamino-1,3-diazacyclopentenes (2) or acid addition salts thereof.
DK115851B (en) Process for the preparation of 1,2-dihydro-4-aryl-quinazolines or acid addition salts thereof.
DK112451B (en) Process for the preparation of [1,2-α] -imidazopyridines or acid addition salts thereof.
DK107942C (en) Process for the preparation of 1,5-disubstituted 3-aza-1-pentanols or acid addition salts thereof.
DK108394C (en) Process for the preparation of substituted imidazo- or pyrimido-quinazolines or acid addition salts thereof.
DK125552B (en) Process for the preparation of 1,2,3,4-tetrahydroisoquinoline-2-carboxamidines or acid addition salts thereof.
DK121604B (en) Process for the preparation of substituted iminocycloheptatriene derivatives or acid addition salts thereof.
DK106381C (en) Process for the preparation of 2-dimethylamino-3,5,6-trimethylpyrazine or acid addition salts thereof.
DK112449B (en) Process for the preparation of 2,3-dihydro-5-pyridyl-1H-1,4-benzodiazepines or acid addition salts thereof.
DK111893B (en) Process for the preparation of substituted methylhydrazines or acid addition salts thereof.
DK105649C (en) Process for the preparation of 2-dimethylaminopyrazine or acid addition salts thereof.
DK106092C (en) Process for the preparation of basic substituted 11-alkyl-5,6-dihydro-6-oxo-morphanthridines or acid addition salts thereof.
DK118667B (en) Process for the preparation of 1,3,4,5-tetrahydro-5-phenyl-2H-1,4-benzodiazepin-2-ones or acid addition salts thereof.
DK118345B (en) Process for the preparation of 2,5-diacylamino-3,6-diamino-1,4-dihydroxybenzenes or acid addition salts thereof.
DK106144C (en) Process for the preparation of aryl-N- (1,2,5,6-tetrahydro-1,3-dialkyl-4-pyridyl) -alkanoylamides or acid addition salts thereof.
DK107170C (en) Process for the preparation of 10-monoalkylaminoalkyl-10,11-dihydro-11-oxo-5H-dibenzo (b, e) (1,4) diazepines or acid addition salts thereof.
DK108856C (en) Process for the preparation of phenylcyclohexylalkylamines or acid addition salts thereof.
DK112530B (en) Process for the preparation of α-phenyl-β-tetrahydofuryl-2-propionitriles or acid addition salts thereof.
DK118241B (en) Process for the preparation of 2-amino-oxazolines or acid addition salts thereof.
DK106911C (en) Process for the preparation of 2,3-dihydro-5-aryl-1H-1,4-benzodiazepine derivatives or acid addition salts thereof.